Pharmaceutical

Image

Global Nootropics Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Oct 2023
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Nootropics Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR - % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 12.41 Billion
Diagram Market Size (Forecast Year) USD 35.03 Billion
Diagram CAGR %

Global Nootropics Market, By Type (Over-the-counter (OTC), Prescription, Natural, Homemade, Others), Indication (Productivity and Study, Socializing, Exercise and Health, Wellbeing, Others), Dosage form (Tablets, Capsules, Injections, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2030.

Nootropics Market Analysis and Size

Nootropics help the brain focus, which is very useful for athletes. As a result, businesses have targeted these customers carefully. For instance, Koios, a nootropic beverage company based in Colorado, promotes its products by hiring elite athletes for advertisements and supporting well-known e-sports teams. Citicoline, Choline bitartrate, Alpha-GPC, Caffeine, and N-Acetyl-L-Tyrosine are examples of naturally produced nootropics that aid in focus enhancement. To meet the overwhelming demand from consumers, goods makers have started releasing new products.

Data Bridge Market Research analyses that the global nootropics market which was USD 12.41 billion in 2022, is expected to reach USD 35.03 billion by 2030, and is expected to undergo a CAGR of 13.85% during the forecast period 2023-2030. “Oral” is expected to dominate the route of administration segment of the global nootropics market owing to the safety profile offered by the oral route and minimal side effects. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Nootropics Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Type (Over-the-counter (OTC), Prescription, Natural, Homemade, Others), Indication (Productivity and Study, Socialising, Exercise and Health, Wellbeing, Others), Dosage form (Tablets, Capsules, Injections, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others)

Countries Covered

U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of the Middle East & Africa

Market Players Covered

Pfizer Inc. (U.S.), GlaxoSmithKline plc (UK), Novartis AG (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Sanofi (France), AstraZeneca (UK), Johnson & Johnson Private Limited (U.S.), Cephalon A/S (Denmark), Reckitt Benckiser Group PLC (UK), Onnit Labs, Inc. (U.S.), Mental Mojo, LLC (U.S.), Noocube (UK), Opti-Nutra Ltd (UK), TruBrain (U.S.), Zhou Nutrition (Utah)

Market Opportunities

  • Increase in the number of research and development activities
  • Rising investment in the development of advanced technologies
  • Surging drug approvals and launches

Market Definition

Nootropics are supplements, smart medications, psychological enhancers, pharmaceuticals, or other substances that can help people with good health improve their cognitive function, specifically executive functions, motivation, creativity, and memory. These are available in both prescription as well as non-prescription forms. Prescription nootropics are drugs that are used to treat conditions such as Alzheimer's disease, attention deficit hyperactivity disorder (ADHD), and narcolepsy. Non-prescription medicines are used to improve concentration and brain performance rather than to treat ailments.

Global Nootropics Market Dynamics

Drivers

  • Increasing Investment in Healthcare Infrastructure

Another significant factor influencing the growth rate of the global nootropics market is the rising healthcare expenditure which helps in improving its infrastructure. Furthermore, rising initiatives by public and private organizations to spread awareness will expand the global nootropics market.

  • Increasing Awareness and Demand

There is a growing awareness of cognitive health and the desire to enhance cognitive performance among individuals. People are seeking ways to improve focus, memory, and overall brain function, leading to a rising demand for nootropics.

  • Wellness and Self-Optimization Trends

There is a growing trend towards personal health optimization and self-improvement across various aspects of life, including cognitive performance. Nootropics are seen as tools for achieving these goals, aligning with the broader wellness and self-optimization movements.

Opportunity

  • Increase in the Number of Research and Development Activities   

The market's growth is fuelled by an increase in the number of research and development activities. This will provide beneficial opportunities for the global nootropics market growth. Along with this, rising drug approvals and launches will further propel the market’s growth rate.

Restraints/Challenges

  • Lack of Regulation and Standardization

The regulatory landscape for nootropics is often complex and inconsistent. The lack of clear regulations can lead to concerns about product quality, safety, and misleading claims. The absence of standardized guidelines and quality control measures makes it challenging for consumers to make informed choices.

  • Limited Scientific Research

Despite the popularity of nootropics, there is still a limited amount of rigorous scientific research to support their efficacy and safety. Many substances in the market have not been extensively studied, and their long-term effects and potential interactions with other medications or health conditions remain largely unknown.

This global nootropics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global nootropics market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

  • In February 2021, Mind Cure Health Inc. announced the launch of its original nootropic and adaptogen product offerings. The current nootropic formulations of MINDCURE's consist 100% organic as well as sustainably cultivated functional mushrooms. MINDCURE's Teen formulation contains safe, all-natural ingredients such as minerals, botanicals, and vitamins which will further decrease sleeplessness, nervousness, and restlessness in teens

Global Nootropics Market Scope

The global nootropics market is segmented on the basis of type, indication, dosage form, route of administration, end-users, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Over-the-Counter (OTC)
  • Prescription
  • Natural
  • Homemade
  • Others

Indication

  • Productivity and Study
  • Socializing
  • Exercise and Health
  • Wellbeing
  • Others

Dosage Form

  • Tablets
  • Capsules
  • Injections
  • Others

Route of Administration

  • Oral
  • Parenteral
  • Others

End-Users

  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

Global Nootropics Market Regional Analysis/Insights

The global nootropics market is analysed and market size insights and trends are provided by type, indication, dosage form, route of administration, end-users, and distribution channel as referenced above.

The countries covered in the global nootropics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the global nootropics market because of the growing focus of major key players on novel technology and rising healthcare as well as research and development expenditure will further propel the market’s growth rate in this region.

Asia-Pacific are expected to grow during the forecast period 2023-2030 due to surging awareness of cognitive health supplements in this region. Also, the development of healthcare infrastructure will further propel the market’s growth rate in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends, and porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.

  Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global nootropics market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kind of products for the global nootropics market, impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the global nootropics market. The data is available for the historic period 2015-2020.

Competitive Landscape and Global Nootropics Market Share Analysis

The global nootropics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global nootropics market.

Some of the major players operating in the global nootropics market are:

  • Pfizer Inc. (U.S.)
  • GlaxoSmithKline plc (U.K.)
  • Novartis AG (Switzerland)
  • Mylan N.V. (U.S.)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Sanofi (France)
  • AstraZeneca (UK U.K.
  • Johnson & Johnson Private Limited (U.S.)
  • Cephalon A/S (Denmark)
  • Reckitt Benckiser Group PLC (U.K.)
  • Onnit Labs, Inc. (U.S.)
  • Mental Mojo, LLC (U.S.)
  • Noocube (U.K.)
  • Opti-Nutra Ltd (U.K.)
  • TruBrain (U.S.)
  • Zhou Nutrition (Utah)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Nootropics Market will be worth USD 35.03 billion by 2030.
The Nootropics Market growth rate is 13.85% during the forecast period.
Increasing Investment in Healthcare Infrastructure, Increasing Awareness and Demand and Wellness and Self-Optimization Trends are the growth drivers of the Nootropics Market.
The type, indication, dosage form, route of administration, end-users, and distribution channel are the factors on which the Nootropics Market research is based.
Mind Cure Health Inc. announced the launch of its original nootropic and adaptogen product offerings & the current nootropic formulations of MINDCURE's consist 100% organic as well as sustainably cultivated functional mushrooms are the latest developments in the Nootropics Market.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials